Clinical Trial: The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title:

Brief Summary: The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.

Detailed Summary:
Sponsor: George Washington University

Current Primary Outcome: Modified Rodnan Skin Score [ Time Frame: 10 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Medsger Severity Score [ Time Frame: 10 years ]

Original Secondary Outcome: Same as current

Information By: George Washington University

Dates:
Date Received: February 3, 2015
Date Started: July 2014
Date Completion:
Last Updated: August 29, 2016
Last Verified: August 2016